+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Multicomponent DNA carrier with a vesicular stomatitis virus G-peptide greatly enhances liver-targeted gene expression in mice



Multicomponent DNA carrier with a vesicular stomatitis virus G-peptide greatly enhances liver-targeted gene expression in mice



Bioconjugate Chemistry 10(6): 1075-1083



Genes can be targeted to hepatocytes in vitro and in vivo by the use of asialoorosomucoid-polylysine conjugates. After systemic application, this nonviral vector is recognized by highly selective asialoglycoprotein (AsGP) receptors on the sinusoidal liver cell membrane and is taken up via receptor-mediated endocytosis. As most of the DNA is rapidly transferred to lysosomes where it is degraded, transfection efficiency is low and gene expression transient. To address this problem, we incorporated a pH-dependent synthetic hemolytic peptide derived of the G-protein of Vesicular Stomatitis Virus (VSV) into the gene transfer system, to increase endosomal escape of internalized DNA. The multicomponent carrier binds DNA in a nondamaging way, is still recognized by the AsGP receptor, and is targeted to the liver in vivo. Injection of DNA complexes containing a luciferase marker gene resulted in luciferase expression of 29 000 pg/g liver which corresponded to an increase of a factor of 10(3) overexpression after injection of DNA complexes without endosomolytic peptide. Furthermore, the amount of intact transgene within isolated liver cell nuclei was increased by a factor of 10(1)-10(2) by the use of the multicomponent carriers. These results demonstrate that incorporation of a hemolytic peptide into a nonviral vector can greatly increase gene expression while retaining cell type targetability in vivo.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011022679

Download citation: RISBibTeXText

PMID: 10563778

DOI: 10.1021/bc990071r


Related references

Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice. Journal of Virology 82(1): 207-219, 2007

Synthesis of rna by mutants of vesicular stomatitis virus indiana serotype and the ability of wild type vesicular stomatitis virus new jersey to complement the vesicular stomatitis virus indiana temperature sensitive g i 114 transcription defect. Journal of Virology 20(1): 157-169, 1976

Inhibition of vesicular stomatitis virus in cells constitutively expressing an antisense RNA targeted against the virus RNA polymerase gene. Journal of General Virology 78: 125-129, 1997

Expression of IFN-beta enhances both efficacy and safety of oncolytic vesicular stomatitis virus for therapy of mesothelioma. Cancer Research 69(19): 7713-7720, 2009

Vesicular stomatitis virus matrix protein gene enhances the antitumor effects of radiation via induction of apoptosis. Apoptosis 13(10): 1205-1214, 2008

Interleukin-12 expression enhances vesicular stomatitis virus oncolytic therapy in murine squamous cell carcinoma. Laryngoscope 117(2): 210-214, 2007

Vaccinia virus recombinants expression of vesicular stomatitis virus genes and protective immunization of mice and cattle. Science (Washington D C) 227(4685): 433-435, 1985

Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response. Journal of Virology 74(17): 7895-7902, 2000

Gene expression of vesicular stomatitis virus genome RNA. Virology 188(2): 417-428, 1992

Expression of the M gene of vesicular stomatitis virus cloned in various vaccinia virus vectors. Journal of Virology 62(3): 776-782, 1988

Oligonucleotide sequence analyses indicate that vesicular stomatitis virus large defective interfering virus particle RNA is made by internal deletion: evidence for similar transcription polyadenylation signals for the synthesis of all vesicular stomatitis virus mRNA species. Journal of Virology 33(2): 807-817, 1980

Studies on carbon di oxide sensitivity in drosophila melanogaster after infection with vesicular stomatitis virus part 2 vesicular stomatitis virus indiana serotype. Annales de l'Institut Pasteur (Paris) 122(5): 1029-1058, 1972

Lysis of target cells infected with vesicular stomatitis virus in the presence of tunicamycin by anti vesicular stomatitis virus cyto toxic t lymphocytes. Journal of Immunology 126(5): 1914-1918, 1981

Oligo nucleotide sequence analyses indicate that vesicular stomatitis virus large defective interfering virus particle rna is made by internal deletion evidence for similar transcription poly adenylation signals for the synthesis of all vesicular stomatitis virus messenger rna species. Journal of Virology 33(2): 807-817, 1980